A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Simple Search

You could also try: every day (783)

Carboplatin-Pembrolizumab-Pemetrexed

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN (AUC 5)-PEMBROLIZUMAB-PEMETREXED Regimen •
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Pembrolizumab-Pemetrexed.pdf

ObinutuzumabVenetoclax LowRisk

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia Obinutuzumab-Venetoclax (Low Risk) Regimen • CLL – Obinutuzumab-Venetoclax (Low Risk) Indication • Chronic
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/ObinutuzumabVenetoclax-LowRisk.pdf

ACCORD-2 master protocol

Description
CONFIDENTIAL ACCORD-2-001 – Master Protocol TITLE PAGE Protocol Title: ACCORD-2: A Multicentre, Seamless, Phase 2 Adaptive Randomisatio
Url
/Media/Southampton-Clinical-Research/COVID-19/ACCORD/ACCORD-2-master-protocol.pdf

Percutaneous endoscopic gastrostomy (PEG) tube insertion aftercare advice - patient information

Description
This factsheet explains what to expect after a percutaneous endoscopic gastrostomy (PEG) tube insertion and how to look after your PEG
Url
/Media/UHS-website-2019/Patientinformation/Endoscopy/Percutaneous-endoscopic-gastrostomy-PEG-tube-insertion-aftercare-advice-3645-PIL.pdf

Inotuzumab Ozogamicin

Description
Relapsed or refractory CD22-positive B-Cell acute lymphoblastic leukaemia.
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/ALL/Inotuzumab-Ozogamicin.pdf

Pazopanib v1.1

Description
Chemotherapy Protocol RENAL CELL PAZOPANIB Regimen Renal Cell - Pazopanib Indication First line treatment option fo
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Pazopanib-v1.1.pdf

Bexarotene

Description
Chemotherapy Protocol Cutaneous T-cell Lymphoma BEXAROTENE Regimen • Cutaneous T-cell Lymp
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bexarotene.pdf

Capecitabine-Mitomycin

Description
Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE-MITOMYCIN Regimen • Colorectal Cancer – Capecitabine-M
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine-Mitomycin.pdf

Capecitabine (21 day)

Description
Chemotherapy Protocol COLORECTAL CANCER CAPECITABINE (21 day) Regimen • Colorectal Cancer – Capecitabine (21 day) Indication • Metastatic / advanced
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Colorectal/Capecitabine21day.pdf

Upadacitinib for the treatment of Crohn's disease and ulcerative colitis - patient information

Description
This factsheet explains what upadacitinib is, how people with Crohn's disease or ulcerative colitis should take it and the possible side
Url
/Media/UHS-website-2019/Patientinformation/Digestionandurinaryhealth/Upadacitinib-for-the-treatment-of-Crohns-disease-and-ulcerative-colitis-3927-PIL.pdf
71 to 80 of 643
Previous … 6 7 8 9 10 … Next